After years in anesthesia, I've noticed the same pharmacology gaps trip up CRNA students over and over. Here are the top 5:

1. MAC vs. ED50 — They're not the same thing. MAC is the alveolar concentration that prevents movement in 50% of patients. ED50 is the dose that produces a therapeutic effect in 50% of the population. Boards love testing whether you know the difference.

2. Succinylcholine's dual mechanism — It's a depolarizing agent, yes. But students forget the Phase II block that can occur with prolonged infusion. Know the difference between Phase I and Phase II — and the clinical signs of each.

3. Local anesthetic toxicity timeline — CNS symptoms hit before cardiac symptoms. Always. If your patient complains of tinnitus or perioral numbness, that's your warning before the seizure, not after.

4. Propofol vs. Etomidate for hemodynamically unstable patients — Propofol drops blood pressure. Etomidate preserves hemodynamic stability. But etomidate suppresses adrenal function — so it's not for septic patients.

5. The Henderson-Hasselbalch trap — Students memorize the equation but can't apply it clinically. If the pKa of lidocaine is 7.9 and tissue pH is 7.4, most of the drug is ionized and CANNOT cross the nerve membrane. That's why local anesthetics don't work well in infected tissue.

These aren't obscure topics — they're core concepts that show up across the NCE. Master them and you'll feel the difference on exam day.

I teach all of this (and a lot more) inside AnesthesiaAcademy — structured study materials, weekly case breakdowns, and a community of CRNA students all working toward the same goal.